62 - 78%
48 - 61%
79 - 93%
34 - 47%
C. 79 - 93%
the size of the prostate correlates well to the degree of obstruction
a decrease of 3 points in IPSS is associated with a subjective perception of improvement
median lobe enlargement gives rise to serious obstructive symptoms
bladder trabeculation is not specific for an obstructing prostate
PVP
HoLEP
HoLRP
TUMT
removing small bladder stones
better access to prostatic fossa
technically, easier trigonization
. When comparing retropubic to suprapubic prostatectomy for removing prostatic adenoma, the former has the advantage of:
frequency, over-flow incontinence, straining, retention
straining, frequency, over-flow incontinence, retention
straining, frequency, retention, over-flow incontinence
frequency, straining, retention, over-flow incontinence
α1-a
α1-b
α2-a
α2-b
TUIP
TURP
HoLEP
HoLRP
before catheterization
after catheterization and before TURP
immediately after TURP
2 weeks after TURP
small prostate
mainly median lobe hypertrophy
history of urinary retention
mainly irritative symptoms
the glandular component of the prostate
the IPSS questionnaire points
the PVR
the transitional zone volume
hematuria
recurrent urinary tract infection
renal insufficiency
all of the above
cetrorelix
flutamide
dutasteride
zanoterone
operating on patients with multiple bladder diverticula
operating on patients who cannot flex their hips and/or knees
unfavorable tissue preservation for pathological examination
. What is (are) the contraindication(s) to open prostatectomy for prostatic adenoma?
renal insufficiency
urinary retention
dry mouth
painless hematuria
the irrigating fluid is at a pressure exceeding 10 mm Hg
the prostate volume is > 45 cc
the resection time is > 90 minutes
all of the above
never
unlikely
likely
always
operation time
duration of in-hospital stay
amount of blood transfused
time to catheter removal
increased intravesical pressure
increased detrusor pressure
increase collagen deposition in the detrusor
detrusor smooth muscle hypertrophy
as a man ages, the responsiveness of prostate cells to androgenic stimuli decreases
adrenal androgens have no role in BPH development
type-1 steroid 5 α-reductase is functionally active in the hair follicle
all of the above
the aim is to occlude the internal iliac vessels
there is a considerable radiation risk during the procedure
bilateral embolization provides better results
eye protection is not required
bladder neck
apex
median lobe
para-collecular
bladder stones
BPH
prostatitis syndrome
. What is (are) the indication(s) of antimuscarinic agents and PDEIs
symptoms begin with a serum sodium of less than 120 mEq/L
the mortality is 2.7-5.8 %
manifestations rely on acute changes in the intravascular volume and plasma solute concentrations
the preferred height of irrigating fluid is 60 cm above the patient
0.2 1%
1.2 2.1%
2.3 3.4%
3.7 5.6%
is specific for prostate symptom
is a seven-question, self-administered questionnaire that yields a total score that ranges from 0 to 35
a sum of 20 on IPSS scale is severe
it covers both voiding and storage symptomatology
62 - 78%
48 - 61%
79 - 93%
34 - 47%
intra-prostatic levels of estrogen decrease in men with BPH
stimulation of the adrenergic nervous system results in a dynamic increase in prostatic urethral resistance
inflammation may play a role through cytokines to promote cell growth
hyperplasia occurs due to an imbalance between cell death and cell proliferation
it focuses on last month`s symptoms
scores of moderate symptoms suggest surgical treatment if the patient`s quality of life was poor
it has been validated and translated to many languages
all of the above
alfuzosin
silodosin
finasteride
tamsulosin
PSA decreases
the prostate size decreases
the complaints resolve
the Q.O.L improves
occurs because of absorption of non-sodium-containing irrigating fluid
occurs only on using unipolar TURP
results in brain edema due to dilutional hyponatremia
positioning the patient in anti-Trendelenburg helps prevent the syndrome